Contents
Sitara Peroxide Limited
Company Information 01
Director Report 02
Condensed Interim Statement of Financial Position 04
Condensed Interim Statement of Profit or Loss Account | 05 |
Condensed Interim Statement of Comprehensive Income | 05 |
Condensed Interim Statement of Changes in Equity | 07 |
Condensed Interim Statement of Cash Flows | 08 |
Condensed Interim Notes to Financial Statements 10
Company Information
Board of Directors
Mr. Yasir Ahmed Awan Chairman
Mr. Imran Ghafoor Chief Executive Officer Mrs. Sharmeen Imran Non-Executive Director
Mr. Haroon Ahmed Zuberi Independent Director
Board Human Resource & Remuneration Committee
Mrs. Sharmeen Imran Chairperson
Mr. Imran Ghafoor Member
Mr. Saqib Anjum Member
Registered Officer
External Auditors RSM-Avais Hyder
Liaqat Nauman Chartered Accountants
Legal Advisor Sahibzada Waqar Arif
Mr. Junaid Makda Non-Executive Director Mr. Saqib Anjum
Non-Executive Director
Mr. Saim Bin Saeed Independent Director
Chief Financial Officer
Mr. Shahid Irshad
Company Secretary
Mr. Mazhar Ali Khan
Head of Internal Audit
Mr. Hafiz Muhammad Tariq
Audit Committee Mr. Saim Bin Saeed Chairman
Mr. Yasir Ahmed Awan Member
Mr. Haroon Ahmed Zuberi Member
Share Registrar
THK Associates (Private) Limited
Plot No. 32-C, Jami Commercial Street 2, DHA, Phase VII, Karachi - 75500, Pakistan.
UAN: (92 21) 111-000-322
Ph: (92 21) 35310183-84
Fax: (92 21) 35310191
601-602, Business Centre, Mumtaz Hassan Road, Off. I. I. Chundrigar Road, Karachi - 74000 Ph : (92 21) 32401373, 32413944
Company Website
https://www.sitaraperoxide.com.pk
Bankers
Al Baraka Bank (Pakistan) Limited Askari Bank Limited
Bank Alfalah Limited Faysal Bank Limited Habib Bank Limited MCB Bank Limited Meezan Bank Limited National Bank Limited Soneri Bank Limited
Standard Chartered Bank (Pakistan) Limited Bank Makramah Limited (BML)
United Bank Limited JS Bank Limited
First Women Bank Limited Bank Al Habib Limited
Habib Metropolitan Bank Limited
Head Office & Project Location 26 - KM Sheikhupura Road, Faisalabad.
Sitara Proxide Limited
1
Ph : (92 41) 2600108, 2600747
The Board of Directors of Sitara Peroxide Limited (the Company) is pleased to present their report together with unaudited condensed interim financial information of the Company for 3rd Quarter ended on March 31, 2025.
Business and Financial Review
The financial results for the nine (9) months of the current financial year in comparison with nine (9) months of the corresponding year are as under.
Financial Highlights | July 2024 to March 2025 | July 2023 to March 2024 |
Rupees | Rupees | |
Sales | 0 | 14,900,700 |
Cost of sales | 0 | 133,273,539 |
Gross (Loss)/Profit | 0 | (118,372,839) |
Other Income | 7,187,500 | 89,193,919 |
(Loss)/Profit before tax | (200,428,882) | (188,954,569) |
(Loss)/(Profit) aDer tax | (144,961,245) | (136,559,129) |
(Loss) per share - basic and diluted | (2.63) | (2.48) |
During nine (9) months under review, the operations of the company remained closed for the envisaged balancing, modernization and replacement (BMR) of plant & machinery and pending overall restructuring of the Company. Accordingly, there is no sales during nine (9) months under review. However, stock-in-hand was already sold during nine (9) months of corresponding period of financial year 2024.
The Company suffered Loss aDer tax Rs 144.961 million during nine (9) months period ended on March 31, 2025 in comparison with Loss aDer tax Rs 136.559 million during corresponding period of nine (9) months ended on March 31, 2024. The administrative expenses are Rs 203.483 million during nine (9) months under review which includes depreciation Rs 137.585 million, salary, wages & benefits Rs 38.190, repair and maintenance of plant & machinery Rs 4.374 million. Finance cost reduced to Rs 4.132 million during nine (9) months of the current financial year in comparison with Rs 18.639 million during corresponding period of nine (9) months due to repayment of Sukuk Facility and its rescheduling at cost of fund, instead of KIBOR based mark-up, signed on December 29,2023 and valid till November 30, 2025.
Loss per share increased to Rs. 2.63 during nine (9) months of the current financial years as compared with Loss per share of Rs. 2.48 during corresponding period of nine (9) months of the last financial year. The management of the Company took all possible austerity measures to further minimize expenses without compromising over legitimate expenses, departmental payments, litigation costs and contingencies.
Future Outlook
The economic conditions of the country and specially that of industries remained challenging during the nine
(9) months under review. The management is vigilant in protecting the interests of all stakeholders, mainly, shareholders, dedicated customers, suppliers etc. and is successfully moving towards to repay all debts and eliminate finance cost thereon. Financial institutions are so far extending due cooperation during the di cult period.
The envisaged BMR will enhance production capacity, e ciency andbetter yield. The management of the Company is in active negotiations with technology supplier and already made an advance payment.
The board would like to express its gratitude to all stakeholders, especially shareholders, for their support and cooperation during last AGM.
By the order of Board of Directors
Faisalabad
HAROON AHMED ZUBERI
Chief Executive Officer
DIRECTOR'S REPORT
17,900, 700 | 0 | ||||
133, 273, 539 | 0 | ||||
(118,372,839) | 0 | ||||
89,193,919 | 7,187,50 0 | ||||
(188,954,569) | (20 0, 428,882) | ||||
(136,559,129) | (1 44,96 1, 245) | ||||
(2.48) | (2.63) |
2025>.Jfi 24
DIRECTOR'S REPORT
SITARA PEROXIDE LIMITED
CONDENSED INTERIM STATEMENT OF FINANCIAL POSITION (UN-AUDITED) AS AT MARCH 31, 2025
(Un-audited) (Audited)
March 31, June 30,
2025 2024
Note Rupees Rupees
ASSETS
Property, plant and equipment | 4 | 2,231,311,422 | 2,368,897,098 | |
Long term advances | 109,626,266 | 109,626,266 | ||
Long term deposits | 52,741,143 | 52,741,143 | ||
2,393,678,831 | 2,531,264,507 | |||
Stores, spare parts and loose tools 119,701,124 | 119,701,124 | |||
Stock in trade | 5 | 218,776,704 | 218,776,704 | |
Trade debts | 64,783,733 | 64,783,733 | ||
Loans and advances | 12,228,094 | 23,295,911 | ||
Taxes refundable due from government | 94,721,985 | 94,951,315 | ||
Cash and bank balances | 4,520,818 | 11,381,255 | ||
514,732,458 | 532,890,042 | |||
Non-current assets
Current assets
Non-current asset held for sale - -
Total assets 2,908,411,289 3,064,154,549
EQUITY AND LIABILITIES
Authorized Capital 60,000,000 (2023: 60,000,000)
Ordinary shares of Rs. 10 each | 600,000,000 | 600,000,000 | ||
Share capital and reserves | ||||
Share capital 55,100,000 (2023: 55,100,000) (Ordinary shares of Rs. 10 each) Revenue reserve Accumulated (loss) Capital reserve | 551,000,000 (846,127,106) | 551,000,000 (720,670,410) | ||
Surplus on revaluation of property, plant and equipment 1,361,740,538 | 1,381,245,086 | |||
1,066,613,431 | 1,211,574,676 | |||
Non-current liabilities
Long term financing Deferred taxation
Current liabilities
-
290,326,714
-
345,794,351
290,326,714 345,794,351
Trade and other payables | 641,248,960 | 595,746,576 | |
Contract liabilities | 114,686,028 | 114,686,028 | |
Loan from chief executive officer | 387,745,131 | 387,878,976 | |
Accrued markup | 281,051,420 | 281,535,983 | |
Current portion of long term financing | 126,739,606 | 126,739,606 | |
Provision for taxation | - | 198,353 | |
1,551,471,145 | 1,506,785,522 | ||
Total equity and liabilities Contingencies and commitments | 6 | 2,908,411,289 3,064,154,549 - - | |
The annexed notes from 1 to 11 form an integral part of these condensed financial statements.
STATEMENT OF FINANCIAL POSITION
STATEMENT OF PROFIT OR LOSS
SITARA PEROXIDE LIMITED CONDENSED INTERIM STATEMENT OF PROFIT OR LOSS (UN-AUDITED) FOR THE NINE MONTHS PERIOD ENDED MARCH 31, 2025
Note
Nine months ended Quarter ended March 31, March 31,
2025 2024 2025 2024
--------------------------- Rupees -------------------------
Revenue from contract with customers | 7 | - | 14,900,700 | - | - | |||
Cost of sale | 8 | - | 133,273,539 | - | 40,878,503 | |||
Gross (loss) | - | (118,372,839) | - | (40,878,503) | ||||
Other income | 7,187,500 | 89,193,919 | 7,187,500 | 884,316 | ||||
7,187,500 | (29,178,920) | 7,187,500 | (39,994,187) | |||||
Distribution cost | - | 3,249,947 | - | 1,283,400 | ||||
Impairment loss on financial assets | - | 78,982,480 | - | - | ||||
Administrative expenses | 203,483,489 | 56,563,877 | 58,467,936 | 14,465,814 | ||||
Other expenses | - | 2,339,993 | - | - | ||||
Finance cost | 4,132,893 | 18,639,352 | 1,356,532 | 1,371,729 | ||||
207,616,382 | 159,775,649 | 59,824,468 | 17,120,943 | |||||
(Loss) for the period before taxation | (200,428,882) | (188,954,569) | (52,636,968) | (57,115,130) | ||||
Provision for taxation | (55,467,637) | (52,395,440) | - | 3,072,197 | ||||
(Loss) for the period | (144,961,245) | (136,559,129) | (52,636,968) | (60,187,327) | ||||
(Loss) per share - Basic and diluted (Rupees) | (2.63) | (2.48) | (0.96) | (1.09) |
The annexed notes from 1 to 11 form an integral part of these condensed financial statements.
STATEMENT OF COMPREHENSIVE INCOME
SITARA PEROXIDE LIMITED CONDENSED INTERIM STATEMENT OF COMPREHENSIVE INCOME (UN-AUDITED) FOR THE NINE MONTHS PERIOD ENDED MARCH 31, 2025
Nine months ended Quarter ended March 31, March 31,
2025 2024 2025 2024
--------------------------Rupe es --------------------------
(Loss) for the period (144,961,245) (136,559,129) (52,636,968) (60,187,327)
Other comprehensive income / (Loss) - - - -Total comprehensive (loss) for the period (144,961,245) (136,559,129) (52,636,968) (60,187,327)
The annexed notes from 1 to 11 form an integral part of these condensed financial statements.
SITARA PEROXIDE LIMITED
CONDENSED INTERIM STATEMENT OF CHANGES IN EQUITY (UN-AUDITED) FOR THE NINE MONTHS PERIOD ENDED MARCH 31, 2025
Issued, subscribed and paid up capital | Accumulated (loss) | Surplus on revaluation of property, plant and equipment | Total |
--------------------------------------Rupees -------------------------------------------
Balance as at July 01, 2023 - (Audited) | 551,000,000 | (622,800,423) | 1,392,584,049 | 1,320,783,626 | |||
Total comprehensive (loss) for the period | |||||||
(Loss) for the period | - | (136,559,129) | - | (136,559,129) | |||
Other comprehensive income | - | - | - | - | |||
- | (136,559,129) | - | (136,559,129) | ||||
Transfer to unappropriated profit on | |||||||
account of incremental depreciation-net of tax | - | 52,994,872 | (52,994,872) | - | |||
Balance as at March 31, 2024 - (Un-audited) | 551,000,000 | (706,364,680) | 1,339,589,177 | 1,184,224,497 | |||
Balance as at July 01, 2024 - (Audited) | 551,000,000 | (720,670,410) | 1,381,245,086 | 1,211,574,676 | |||
Total comprehensive (loss) for the period | . | ||||||
Loss for the period | - | (144,961,245) | - | (144,961,245) | |||
Other comprehensive income | - | - | - | - | |||
- | (144,961,245) | - | (144,961,245) | ||||
Transfer to unappropriated profit on | |||||||
account of incremental depreciation-net of tax | - | 19,504,548 | (19,504,548) | - | |||
Balance as at March 31, 2025 - (Un-audited) | 551,000,000 | (846,127,106) | 1,361,740,538 | 1,066,613,431 |
The annexed notes from 1 to 11 form an integral part of these condensed financial statements.
STATEMENT OF CHANGES IN EQUITY
SITARA PEROXIDE LIMITED CONDENSED INTERIM STATEMENT OF CASH FLOWS (UN-AUDITED) FOR THE NINE MONTHS PERIOD ENDED MARCH 31, 2025
Period Ended March 31,
2025 2024
-------------Rupees '-------------
CASH FLOWS FROM OPERATING ACTIVITIES
(Loss) for the period before taxation
(200,428,882)
(188,954,569)
Adjustments for :
Depreciation of property, plant and equipment
137,585,676
114,985,357
Profit on bank deposit
(10,184)
(33,412)
Provision for staff retirement benefits
-
9,854,420
(Gain) on disposal of operating assets
-
(85,675,442)
(Gain) on disposal of non-current asset held for sale
(Gain) on disposal of investment property
-
-
Impairment loss on financial assets
-
78,982,480
Provision for sale tax refundable
-
0
Bad debt wrtten off
-
-2,339,993
Finance cost
4,132,893
18,639,352
Operating cash flows before working capital changes
(58,720,497)
(54,541,807)
Changes in working capital
(Increase) / decrease in current assets
Stores, spares and loose tools
-
-349,697
Stock in trade
-
5,937,887
Trade debts
-
(35,522,181)
Loans and advances
11,067,817
7,719,386
Deposits and prepayments
-
-
Taxes refundable due from government - sales tax
-
-
Increase / (decrease) current liabilities
Trade and other payables
45,502,384
23,547,976
Contract liability
(0)
-9,257,552
56,570,200
(7,924,181)
Cash (used in) operating activities
(2,150,297)
(62,465,988)
Staff retirement benefits paid
-
(200,000)
Finance cost paid
(4,617,456)
(397,829)
Income tax received / (paid)
30,977
54,783,771
Sales Tax refunded / (paid)
Net cash (used in) operating activities
-
(6,736,775)
-
(8,280,045)
STATEMENT OF CASH FLOWS
CASH FLOWS FROM INVESTING ACTIVITIES
Period Ended March 31,
2025 2024
-------------Rupees -------------
Additions in property, plant and equipment - -Profit on bank deposit 10,184 33,412
Proceeds from disposal of non current asset held for sale - 142,853,346
Increase in long term deposit - -
Net cash generated from / (used in) investing activities 10,184 142,886,758
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of long term financing Short term financing excluding running finance Loan from chief executive officer | - -(133,845) | (181,753,103) -43,273,131 | |
Net cash (used in) / generated from financing activities | (133,846) | (138,479,972) | |
Net (decrease) / increase in cash and cash equivalents (a+b+c) | (6,860,437) | -3,873,259 | |
Cash and cash equivalents at the beginning of the period | 11,381,255 | 9,138,135 | |
Cash and cash equivalents at the end of the period | 4,520,818 | 5,264,876 |
The annexed notes from 1 to 11 form an integral part of these condensed financial statements.
STATEMENT OF CASH FLOWS
SITARA PEROXIDE LIMITED NOTES TO THE CONDENSED INTERIM FINANCIAL STATEMENTS (UN-AUDITED) FOR THE NINE MONTHS PERIOD ENDED MARCH 31, 2025
STATUS AND ACTIVITIES
Sitara Peroxide Limited (the Company) is incorporated in Pakistan as a public limited Company under the Companies Ordinance, 1984 (Repealed with the enactment of the Companies Act 2017 on May 30, 2017) and is listed on Pakistan stock exchange. The principal activity of the Company is manufacturing and sale of hydrogen peroxide (H2O2) and Sitara Safe (disinfectant). The registered office of the Company is situated at 601-602 Business Centre, Mumtaz Hasan Road, Karachi in the province of Sindh and the manufacturing facilities are located at 26 - km Sheikhupura Road, Faisalabad in the province of Punjab.
STATEMENT OF COMPLIANCE
2.1
2.2
2.3
2.4
2.5
These condensed interim financial statements of the Company for the nine months period ended March 31, 2024 have been prepared in accordance with the accounting and reporting standards as applicable in Pakistan for interim financial reporting. The accounting and reporting standards as applicable in Pakistan for interim financial reporting comprise of International Accounting Standard (IAS) 34, Interim Financial Reporting, issued by the International Accounting Standards
Board (IASB) as notified under the Companies Act, 2017 and provisions of and directives issued under the Companies Act, 2017. In case where the provisions of and directives issued under the Companies Act, 2017 differ with the requirements of IAS 34, the provisions of and directives issued under the Companies Act, 2017 have been followed.
These condensed interim financial statements are un-audited but subject to limited scope review by the auditors of the Company and is being submitted to the shareholders as required under section 237 of the Companies Act, 2017.
These condensed interim financial statements are un-audited.
These condensed interim financial statements do not include all the information required for complete set of financial statements, and should be read in conjunction with the Company's published audited financial statements for the year ended june 30, 2024. Comparative balance sheet is extracted from annual audited financial statements for the year ended June 30, 2024 whereas comparative profit and loss account, comparative statement of comprehensive income, comparative statement of changes in equity and comparative cash flow statement are stated from un-audited condensed interim financial statements for the nine months ended on March 31, 2024.
These condensed interim financial statements have been presented in Pak Rupee, which is the Company's functional and presentation currency.
SIGNIFICANT ACCOUNTING POLICIES
The accounting policies and the methods of computation adopted in the preparation of these condensed interim financial statements are the same as those applied in the preparation of the annual audited financial statements for the year ended 30 June 2024.
NOTES TO THE FINANCIAL STATEMENTS
PROPERTY PLANT AND EQUIPMENT
Note
(Un-audited) (Audited) 31-Mar June 30,
2025 2024
------------- Rupees------------------
Operating assets 4.1 2,231,311,422 2,368,897,098
Operating assets
Book value at beginning of period / year 2,368,897,098 2,557,848,157 Addition during the period - -
Disposals during the period / year - (5,132,586) Depreciation charged during the period / year (137,585,676) (183,818,472)
2,231,311,421 2,368,897,098
STOCK IN TRADE
Raw material 21,702,674 21,702,674
Packing material 1,803,900 1,803,900
Working solution 195,270,130 195,270,130
Finished goods - -
218,776,704 218,776,704
CONTINGENCIES & COMMITMENTS
Contingencies
There is no significant change in contingent liabilities since the date of published audited financial statements for the year ended June 30, 2024.
NOTES TO THE FINANCIAL STATEMENTS
(Un-audited) (Un-audited)
Nine Months Ended March 31, Three Months Ended March 31,
2025 2024 2025 2024
----------------------------- Rupees in '000' ------------------------------
REVENUE FROM CONTRACT WITH CUSTOMERS
Local Sales - 14,900,700 - -Less: Commission and discount - - - -
- 14,900,700 - -
COST OF SALES
Cost of goods manufactured
Finished goods
80,371,148
120,474,651
775,000
40,878,503
-Opening
-Closing
-
-
12,798,888
-
-
-
-
-
-
12,798,888
-
-
80,371,148
133,273,539
775,000
40,878,503
AGGREGATE TRANSACTIONS WITH RELATED PARTIES
Name of the related party
Relationship and Percentage
Transactions during the period
Un-Audited
Nine month ended
2025
2024
----------- Rupees ----------
The related parties comprise associated companies, directors, keymanagement personnel and post employment benefit plans. The Company did not carried out any significant transactions with various related parties in Nine months period ended 31 March 2025.
March 31,
Chief executive
Loan obtained
48,400,000
48,400,000.00
officer
Loan repaid
5,126,869
5,126,869.00
Mr. Imran
Ghafoor
NOTES TO THE FINANCIAL STATEMENTS
DATE OF AUTHORISATION FOR ISSUE
These condensed interim financial statements were authorised for issue on 24-10-2025 by the Board of Directors of the Company.
GENERAL
11.1
11.2
11.3
Provisions for taxation made in these condensed interim financial statements are subject to adjustment in annual financial statements.
There is no unusual item included in these condensed interim financial statements which is affecting equity, liabilities, assets, (loss), comprehensive (loss) or cash flows of the Company.
Figures have been rounded off to the nearest of Rupees.
Chief Executive Officer
Chief Financial Officer
Director
NOTES TO THE FINANCIAL STATEMENTS
0335-5557717
601-602 Business Centre, Mumtaz Hassan Road, Off. I.I. Chundrigar Road, Karachi-74000.
Ph: 021 32401373, 32413944
